Other Stories

Full Video

U.S. FDA's vaccine advisory panel to vote on Friday on booster shots for general public Updated: 2021-09-17 07:04:20 KST

In the U.S., the debate on COVID-19 booster shots will reach its conclusion on Friday as the FDA's vaccine advisory panel is set to vote on whether to approve the shot for most Americans.
The scientific community has been split on the matter with a recent article in The Lancet saying boosters aren't needed for most of the general public.
They insist more lives could be saved if the supply is distributed to those not yet vaccinated.
However, Pfizer argues that, as immunity wanes over time, another dose is necessary.
The U.S. is ready to roll out the booster shots, and some severely ill Americans have already received them.
While Friday's vote is not binding, the FDA typically abides by the panel's decision.
Reporter : tkim@arirang.com
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.